LOSS PER COMMON SHARE	6 Months Ended
Jun. 30, 2019
Earnings Per Share [Abstract]
LOSS PER COMMON SHARE	10. LOSS PER COMMON SHARE Basic loss per common share is computed using the weighted average number of common shares outstanding. Diluted loss per common share for the three and six months ended June 30, 2019 and 2018 is computed using the weighted-average number of common shares outstanding adjusted for the incremental shares attributed to outstanding options to purchase common stock, as well as unvested RSUs. Incremental shares of 37,354 were not used in the calculation of diluted income per common share in the three and six months ended June 30, 2019, as the Company is at a loss position and these shares would be considered anti-dilutive. Incremental shares of 64,287 were not used in the calculation of diluted loss per common share in the three and six months ended June 30, 2018, as the Company is at a loss position and these shares would be considered anti-dilutive. Incremental shares of 45,249 were not used in the calculation of diluted loss per common share in the three and six months ended June 30, 2018, as their exercise price was in excess of the Company’s average stock price for the respective period and, accordingly, these shares are not assumed to be exercised for the diluted earnings per share calculation, as they would be anti-dilutive.

LOSS PER COMMON SHARE

6 Months Ended

Jun. 30, 2019

10. LOSS PER COMMON SHARE

Basic loss per common share is computed using the weighted average number of common shares outstanding. Diluted loss per common share for the three and six months ended June 30, 2019 and 2018 is computed using the weighted-average number of common shares outstanding adjusted for the incremental shares attributed to outstanding options to purchase common stock, as well as unvested RSUs. Incremental shares of 37,354 were not used in the calculation of diluted income per common share in the three and six months ended June 30, 2019, as the Company is at a loss position and these shares would be considered anti-dilutive. Incremental shares of 64,287 were not used in the calculation of diluted loss per common share in the three and six months ended June 30, 2018, as the Company is at a loss position and these shares would be considered anti-dilutive. Incremental shares of 45,249 were not used in the calculation of diluted loss per common share in the three and six months ended June 30, 2018, as their exercise price was in excess of the Company’s average stock price for the respective period and, accordingly, these shares are not assumed to be exercised for the diluted earnings per share calculation, as they would be anti-dilutive.